Clinical Trials Browser

Phase 2 × epigallocatechin gallate × Gastrointestinal × Clear all

NCT06015022 2025-09-05

CATCH-B

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Phase 2 Unknown

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms